COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,479 Articles (22,358 medRxiv, 8,121 bioRxiv)

Most recent first Previous |  Page 32: Articles 311-320  | Next

Allostery links hACE2 binding, pan-variant neutralisation and helical extension in the SARS-CoV-2 Spike protein
Colyer, A., Wolf, E., Lento, C., Ustav, M., Sljoka, A., Wilson, D. J.
10.1101/2025.01.28.635280 — Posted: 2025-01-29
Long COVID affects working memory: Assessment using a single rapid online test
Asghar, A., Yuen, H. K., Aksoy, M., Salawu, A., Baseler, H.
10.1101/2025.01.26.25321152 — Posted: 2025-01-28
Association of memory function with COVID-19 outcomes in adults aged 50 years and older: Analysis of three prospective cohorts
Shi, J., Shen, X., Tian, Y., Lu, R., Li, J., Geng, X., Zhai, S., Jia, X., Ji, F., Dang, S., Wang, W.
10.1101/2025.01.24.25321065 — Posted: 2025-01-28
Accelerated Adaptation of SARS-CoV-2 Variants in Mice Lacking IFITM3 Preserves Distinct Tropism and Pathogenesis
Denz, P. J., Papa, J. L., McFadden, M. I., Rao, P. R., Roettger, J., Forero, A., Yount, J. S.
10.1101/2025.01.27.635150 — Posted: 2025-01-28
The Interplay of Furin Cleavage and D614G in Modulating SARS-CoV-2 Spike Protein Dynamics
Shoemaker, S. R., Luo, M., Dam, K.-M. A., Pak, J. E., Hoffmann, M. A. G., Marqusee, S.
10.1101/2025.01.27.635166 — Posted: 2025-01-28
SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
Sims, A., Weir, D., Cole, S. J., Hutchinson, E.
10.1101/2025.01.26.634807 — Posted: 2025-01-27
Addressing SARS-CoV-2 Evolution: Neutralization of Emerging Variants of Concern by the AVX/COVID-12 'Patria' Vaccine Based on HexaPro-S Ancestral Wuhan Spike or Its Updated BA.2.75.2 Version
Carballo-Uicab, G., Mellado-Sanchez, G., Gonzalez-Gonzalez, E., Salinas-Trujano, J., Mendoza-Salazar, I., Lopez-Olvera, K., Gomez-Castellano, K. M., Salazar, M. I., Torres-Flores, J. M., Chagoya-Cortes, H. E., Paz-De la Rosa, G., Mena, I., Rojas-Martinez, O., Lara-Puente, J. H., Peralta-Sanchez, G. J., Sarfati-Mizrahi, D., Torres-Flores, A., Sun, W., Krammer, F., Garcia-Sastre, A., Palese, P., Lopez-Macias, C., Lozano-Dubernard, B., Perez-Tapia, S. M., Almagro, J. C.
10.1101/2025.01.23.634579 — Posted: 2025-01-27
Molecular Mechanisms of Drug Resistance and Compensation in SARS-CoV-2 Main Protease: The Interplay Between E166 and L50
Zvornicanin, S. N., Shaqra, A. M., Flynn, J., Carias Martinez, H., Jia, W., Moquin, S., Dovala, D., Bolon, D. N., Kurt Yilmaz, N., Schiffer, C. A.
10.1101/2025.01.24.634813 — Posted: 2025-01-27
Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
Horby, P. W., Emberson, J. R., Peto, L., Staplin, N., Campbell, M., Pessoa-Amorim, G., Stewart, R., Ghosh, D., Cooke, G., Blencowe, N., Moreno-Cuesta, J., Desai, P., Hine, P., Underwood, J., Easom, N., Majumdar, J., Bhagani, S., Baillie, J. K., Buch, M. H., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Montgomery, A., Mukherjee, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2025.01.24.25321081 — Posted: 2025-01-27
Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more robust among Kenyan compared to Swedish adults
Wanjiku, p., Orindi, B., Mwacharo, J., Chemweno, J., Karanja, H., Kronsteiner-Dobramysl, B., Kai, O., Wright, D., Ochola-Oyier, L. I., Sundling, C., Dunachie, S., Warimwe, G. M., Farnert, A., Bejon, P., Ndungu, F. M., Nduati, E.
10.1101/2025.01.24.25321024 — Posted: 2025-01-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).